CLGN Q4 2025 Earnings EPS Misses Estimates as Biotech Continues PreRevenue Phase COCH Q1 2026 Earnings Significant EPS Beat Amid Revenue Uncertainty MITQ Q1 2026 Earnings Narrowed Loss Reflects Operational Discipline ATS Q1 2026 Earnings EPS Surpasses Estimates by 924 Stock Rises 391 C4 Therapeutics Q1 2026 Earnings Narrower Loss Surprises as Biotech Advances Pipeline Rapid7 Q1 2026 Earnings EPS Surpasses Expectations Stock Rises